Jefferies Downgrades Eli Lilly (LLY) to Underperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/23/2024
- Stocks gear up for Big Tech earnings; yen toys with danger zone
- JPMorgan is worried about further S&P 500 sell-off potential
- Oil rises on robust EU data as Mideast tensions linger
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- SAP Q1 results fall short of Wall Street estimates as transformation kicks off
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Kroger (KR), Albertsons and C&S Wholesale Grocers Announce an Updated and Expanded Divestiture Plan
- Costar Group (CSGP) to Acquire Matterport (MTTR) for $5.50/sh Cash and Stock
- Jaguar Health (JAGX) Files $75M Mixed Shelf
- Apple (AAPL) PT Lowered to $210 at Morgan Stanley, 'We'd buy post-earnings weakness'
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
Jefferies Downgrades AstraZeneca (AZN) to Underperform
October 11, 2013 7:58 AM EDTJefferies downgraded AstraZeneca (NYSE: AZN) from Hold to Underperform and lowers its price target from 2,850.00p to 2,600.00p.
"We have downgraded AstraZeneca to Underperform from Hold as it is another strong bond proxy in our view with poor base business fundamentals," analyst... More
Edward Jones Upgrades Eli Lilly (LLY) to Hold
October 10, 2013 6:45 AM EDTEdward Jones upgraded Eli Lilly (NYSE: LLY) from Sell to Hold.
For an analyst ratings summary and ratings history on Eli Lilly click here. For more ratings news on Eli Lilly click here.
Shares of Eli Lilly closed at $47.96 yesterday, with a 52 week range of $44.88-$58.41.... More
